TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Divanmedicin AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
227
|
247 | |
| Financial expenses |
2
|
7 | |
| Earnings before taxes |
54
|
47 | |
| EBITDA |
39
|
38 | |
| Total assets |
468
|
444 | |
| Current assets |
26
|
66 | |
| Current liabilities |
59
|
60 | |
| Equity capital |
368
|
373 | |
| - share capital |
8
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
78.6%
|
84.0% | |
| Turnover per employee |
114
|
124 | |
| Profit as a percentage of turnover |
23.8%
|
19.0% | |
| Return on assets (ROA) |
12.0%
|
12.2% | |
| Current ratio |
44.1%
|
110.0% | |
| Return on equity (ROE) |
14.7%
|
12.6% | |
| Change turnover |
5
|
52 | |
| Change turnover % |
15%
|
2%
|
27% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
100% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.